Evidence map›Paper›PMID 42613435›Full record

ArticleLeukemia2026

Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

Sonja Zweegman, Saad Z Usmani, Vania Hungria, Nizar J Bahlis, Christopher P Venner, Marc Braunstein, Ludek Pour, Josep M Marti, Supratik Basu, Yael C Cohen and 12 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sonja ZweegmanAmsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. s.zweegman@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-5011-1820
Saad Z UsmaniMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5484-8731
Vania HungriaClínica Médica São Germano, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-4327-1957
Nizar J BahlisArnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0001-7353-7034
Christopher P VennerCross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Marc BraunsteinPerlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Ludek PourUniversity Hospital Brno, Brno, Czech Republic.
Josep M MartiHospital Universitario Mútua de Terrassa, Terrassa, Spain.
Supratik BasuRoyal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, UK.ORCID http://orcid.org/0000-0003-2206-4796
Yael C CohenTel Aviv Sourasky (Ichilov) Medical Center, Tel Aviv, Israel.ORCID http://orcid.org/0000-0002-9061-7287
Morio MatsumotoNational Hospital Organization Shibukawa Medical Center, Gunma, Japan.
Kenshi SuzukiJapanese Red Cross Medical Center, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7132-5337
Cyrille HulinHôpital Haut Lévêque, University Hospital, Pessac, France.ORCID http://orcid.org/0000-0002-3749-5161
Sebastian GrosickiSchool of Public Health, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0003-2644-1050
Wojciech LegiecSt. John of Dukla Oncology Center of Lublin Land, Lublin, Poland.
Angelo MaiolinoInstituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-0140-9548
Mai NgoJohnson & Johnson, Titusville, NJ, USA.
Lorena Lopez-MasiJohnson & Johnson, Raritan, NJ, USA.
Fredrik BorgstenJohnson & Johnson, Raritan, NJ, USA.
Melissa RoweJohnson & Johnson, High Wycombe, UK.
Robin L CarsonJohnson & Johnson, Spring House, PA, USA.
Thierry FaconUniversity of Lille, CHU de Lille, Lille, France.ORCID http://orcid.org/0000-0001-7705-8460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42613435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.